Katherine Hollywood

Katherine Hollywood serves as the Senior Technical Specialist for Mass Spectrometry & Separations at the Manchester Institute of Biotechnology and the School of Chemistry, University of Manchester. She holds overall responsibility for facilities supporting research across the Faculty of Science and Engineering (FSE), the wider university, and external collaborations. With a PhD earned in 2010 under Prof. Roy Goodacre, her career spans post-doctoral research, SYNBIOCHEM involvement, and current leadership in analytical techniques.

Her educational background includes a PhD from the University of Manchester (2010) focusing on bioanalytical techniques for skin diseases with emphasis on untargeted metabolomics. Her doctoral research, The Development of Bio-Analytical Techniques for the Treatment of Psoriasis and Related Skin Disorders, established her expertise in applying advanced analytical methods to clinical problems.

Dr. Hollywood's research interests center on metabolomics, mass spectrometry applications, and bioanalytical technique development. She specializes in untargeted metabolomics approaches for clinical diagnosis and biomarker discovery, with significant contributions to Parkinson's disease research, aging studies, and synthetic biology applications. Her work intersects with multiple UN Sustainable Development Goals, particularly those addressing health and wellbeing through advanced diagnostics and biotechnology.

Analysis of her 15 most recent publications reveals a strong focus on translational research bridging analytical chemistry with clinical applications. Her work spans neurodegenerative disease biomarkers (particularly Parkinson's), aging research incorporating ethnic diversity considerations, microbial engineering for compound production, analytical method validation for biosurfactants, and pandemic response diagnostics. The predominant methodologies involve advanced mass spectrometry techniques, particularly gas chromatography-mass spectrometry and LC-MS/MS approaches.

Her research has been recognized through significant project funding, including leadership as Principal Investigator on the High Resolution Metabolomics project (2023-2024) and the 21ALERT initiative (2022-2023), along with contributions as Co-Investigator on multiple collaborative grants addressing microbiome engineering, protein dynamics, and synthetic biology applications.

Dr. Hollywood actively participates in knowledge dissemination through the British Science Week Schools' Fair and media engagement on metabolomics applications. Her work on the Parkinsons Super Smeller project demonstrates commitment to health impact through innovative diagnostic approaches, while her research on meat adulteration detection shows application of metabolomics to food safety challenges.